Koppel Adam
CIK: 0001578965
Director10% Owner
Primary company: Dicerna Pharmaceuticals Inc (DRNA)
Koppel Adam is a corporate insider at Dicerna Pharmaceuticals Inc (DRNA) filing SEC Form 4 transactions. 97 transactions across 9 companies, totaling $268,372,603 in purchases and $23,589,000 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Conversion | 4,145,768 | - | - | 0 | 4/20/2026 Filed: 4/20/2026 | Filing → | |
| Conversion | 16,875,000 | - | - | 0 | 4/20/2026 Filed: 4/20/2026 | Filing → | |
| Purchase | 1,562,500 | $16.00 | $25.00M | 22,583,268 | 4/20/2026 Filed: 4/20/2026 | Filing → | |
| Conversion | 4,145,768 | - | - | 21,020,768 | 4/20/2026 Filed: 4/20/2026 | Filing → | |
| Conversion | 16,875,000 | - | - | 16,875,000 | 4/20/2026 Filed: 4/20/2026 | Filing → | |
| Award | 38,300 | $16.00 | $613K | 38,300 | 4/16/2026 Filed: 4/20/2026 | Filing → | |
Cerevel Therapeutics Holdings, Inc. CERE | Disposition | 80,189 | - | - | 0 | 8/1/2024 Filed: 8/5/2024 | Filing → |
Cerevel Therapeutics Holdings, Inc. CERE | Disposition | 65,679,781 | - | - | 0 | 8/1/2024 Filed: 8/5/2024 | Filing → |
Cerevel Therapeutics Holdings, Inc. CERE | Disposition | 10,461 | - | - | 0 | 8/1/2024 Filed: 8/5/2024 | Filing → |
Cerevel Therapeutics Holdings, Inc. CERE | Disposition | 3,282 | - | - | 10,461 | 8/1/2024 Filed: 8/5/2024 | Filing → |
| Award | 16,000 | $5.52 | $88K | 16,000 | 6/26/2024 Filed: 6/28/2024 | Filing → | |
Cerevel Therapeutics Holdings, Inc. CERE | Award | 10,461 | - | - | 13,743 | 6/5/2024 Filed: 6/7/2024 | Filing → |
| Award | 904,160 | $5.53 | $5.00M | 4,034,582 | 1/11/2024 Filed: 1/12/2024 | Filing → | |
Cerevel Therapeutics Holdings, Inc. CERE | Purchase | 5,480,052 | $22.81 | $125.00M | 65,679,781 | 10/16/2023 Filed: 10/18/2023 | Filing → |
| Award | 16,000 | $0.00 | $0 | 16,000 | 6/21/2023 Filed: 6/22/2023 | Filing → | |
Cerevel Therapeutics Holdings, Inc. CERE | Award | 13,780 | $0.00 | $0 | 13,780 | 6/7/2023 Filed: 6/9/2023 | Filing → |
Cerevel Therapeutics Holdings, Inc. CERE | J | 432,627 | $0.00 | $0 | 60,199,729 | 6/7/2023 Filed: 6/9/2023 | Filing → |
Cerevel Therapeutics Holdings, Inc. CERE | Award | 3,282 | - | - | 3,282 | 6/7/2023 Filed: 6/9/2023 | Filing → |
| Award | 9,650 | $0.00 | $0 | 9,650 | 6/6/2023 Filed: 6/8/2023 | Filing → | |
| Award | 9,650 | $0.00 | $0 | 9,650 | 12/13/2022 Filed: 12/15/2022 | Filing → |
Type
Conversion
Shares
4,145,768
Price
-
Value
-
Type
Conversion
Shares
16,875,000
Price
-
Value
-
Type
Purchase
Shares
1,562,500
Price
$16.00
Value
$25.00M
Type
Conversion
Shares
4,145,768
Price
-
Value
-
Type
Conversion
Shares
16,875,000
Price
-
Value
-
Type
Award
Shares
38,300
Price
$16.00
Value
$613K
Cerevel Therapeutics Holdings, Inc.
CERE
Type
Disposition
Shares
80,189
Price
-
Value
-
Cerevel Therapeutics Holdings, Inc.
CERE
Type
Disposition
Shares
65,679,781
Price
-
Value
-
Cerevel Therapeutics Holdings, Inc.
CERE
Type
Disposition
Shares
10,461
Price
-
Value
-
Cerevel Therapeutics Holdings, Inc.
CERE
Type
Disposition
Shares
3,282
Price
-
Value
-
Type
Award
Shares
16,000
Price
$5.52
Value
$88K
Cerevel Therapeutics Holdings, Inc.
CERE
Type
Award
Shares
10,461
Price
-
Value
-
Type
Award
Shares
904,160
Price
$5.53
Value
$5.00M
Cerevel Therapeutics Holdings, Inc.
CERE
Type
Purchase
Shares
5,480,052
Price
$22.81
Value
$125.00M
Type
Award
Shares
16,000
Price
$0.00
Value
$0
Cerevel Therapeutics Holdings, Inc.
CERE
Type
Award
Shares
13,780
Price
$0.00
Value
$0
Cerevel Therapeutics Holdings, Inc.
CERE
Type
J
Shares
432,627
Price
$0.00
Value
$0
Cerevel Therapeutics Holdings, Inc.
CERE
Type
Award
Shares
3,282
Price
-
Value
-
Type
Award
Shares
9,650
Price
$0.00
Value
$0
Type
Award
Shares
9,650
Price
$0.00
Value
$0
AI Agent
Try asking...